Condition (MeSH)
Nails, Malformed
ClinicalTrials.gov lists 8 trials for Nails, Malformed or a narrower condition beneath it. Pfizer has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
8 of the 8 trials are tagged with Nails, Malformed itself; the rest are tagged with a narrower condition beneath it.
When did Nails, Malformed trials start? (7)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2015 | 1 |
| 2011 | 1 |
| 2010 | 1 |
| 1994 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 8 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Nails, Malformed trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 3 |
How many Nails, Malformed trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Nails, Malformed trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Pfizer | 2 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
Which serious adverse events do Nails, Malformed trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Coronary artery disease (unrelated) | 2 | 1 |
| Osteoarthritis (unrelated) | 2 | 1 |
| Pulmonary embolism (unrelated) | 2 | 2 |
| Acute myocardial infarction (unrelated) | 1 | 1 |
| Anaemia (unrelated) | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Nails, Malformed? (15)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Epidemiological study of onychomycosis in older adults with onychodystrophy. | Geriatrics & gerontology international | 2016 | Yes |
| Pediatric nail conditions. | Clinics in dermatology | 2013 | Yes |
| Clinical and pathological features of pachyonychia congenita. | The journal of investigative dermatology. Symposium proceedings | 2005 | Yes |
| Pincer nails: a new surgical treatment. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] | 2001 | Yes |
| Pincer nails: definition and surgical treatment. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] | 2001 | Yes |
Showing 5 of 15 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.